The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19.
AstraZeneca’s Injectable Antibody Cocktail Halves Risk Of Death Or Developing Severe Covid, Trial Finds
The British pharma firm has already asked U.S. regulators for emergency approval to use the antibody cocktail to prevent symptomatic Covid-19.